These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1306 related articles for article (PubMed ID: 26184442)

  • 1. Different effects of dopaminergic medication on perceptual decision-making in Parkinson's disease as a function of task difficulty and speed-accuracy instructions.
    Huang YT; Georgiev D; Foltynie T; Limousin P; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2015 Aug; 75():577-87. PubMed ID: 26184442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Perceptual decision-making in patients with Parkinson's disease.
    Djamshidian A; O'Sullivan SS; Lawrence AD; Foltynie T; Aviles-Olmos I; Magdalinou N; Tomassini A; Warner TT; Lees AJ; Averbeck BB
    J Psychopharmacol; 2014 Dec; 28(12):1149-54. PubMed ID: 25237123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subthalamic nucleus deep brain stimulation induces impulsive action when patients with Parkinson's disease act under speed pressure.
    Pote I; Torkamani M; Kefalopoulou ZM; Zrinzo L; Limousin-Dowsey P; Foltynie T; Speekenbrink M; Jahanshahi M
    Exp Brain Res; 2016 Jul; 234(7):1837-1848. PubMed ID: 26892884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Decision-making under risk is improved by both dopaminergic medication and subthalamic stimulation in Parkinson's disease.
    Boller JK; Barbe MT; Pauls KA; Reck C; Brand M; Maier F; Fink GR; Timmermann L; Kalbe E
    Exp Neurol; 2014 Apr; 254():70-7. PubMed ID: 24444545
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effects of dopaminergic medication on dynamic decision making in Parkinson's disease.
    Osman M; Ryterska A; Karimi K; Tu L; Obeso I; Speekenbrink M; Jahanshahi M
    Neuropsychologia; 2014 Jan; 53():157-64. PubMed ID: 24269857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopaminergic contributions to distance estimation in Parkinson's disease: a sensory-perceptual deficit?
    Ehgoetz Martens KA; Ellard CG; Almeida QJ
    Neuropsychologia; 2013 Jul; 51(8):1426-34. PubMed ID: 23643554
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The subthalamic nucleus and inhibitory control: impact of subthalamotomy in Parkinson's disease.
    Obeso I; Wilkinson L; Casabona E; Speekenbrink M; Luisa Bringas M; Álvarez M; Álvarez L; Pavón N; Rodríguez-Oroz MC; Macías R; Obeso JA; Jahanshahi M
    Brain; 2014 May; 137(Pt 5):1470-80. PubMed ID: 24657985
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Basal ganglia, dopamine and temporal processing: performance on three timing tasks on and off medication in Parkinson's disease.
    Jones CR; Malone TJ; Dirnberger G; Edwards M; Jahanshahi M
    Brain Cogn; 2008 Oct; 68(1):30-41. PubMed ID: 18378374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of dopaminergic medications on the time course of explicit motor sequence learning in Parkinson's disease.
    Kwak Y; Müller ML; Bohnen NI; Dayalu P; Seidler RD
    J Neurophysiol; 2010 Feb; 103(2):942-9. PubMed ID: 20018839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decisions under risk in Parkinson's disease: preserved evaluation of probability and magnitude.
    Sharp ME; Viswanathan J; McKeown MJ; Appel-Cresswell S; Stoessl AJ; Barton JJ
    Neuropsychologia; 2013 Nov; 51(13):2679-89. PubMed ID: 23954375
    [TBL] [Abstract][Full Text] [Related]  

  • 11. L-Dopa medication remediates cognitive inflexibility, but increases impulsivity in patients with Parkinson's disease.
    Cools R; Barker RA; Sahakian BJ; Robbins TW
    Neuropsychologia; 2003; 41(11):1431-41. PubMed ID: 12849761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic modulation of striato-frontal connectivity during motor timing in Parkinson's disease.
    Jahanshahi M; Jones CR; Zijlmans J; Katzenschlager R; Lee L; Quinn N; Frith CD; Lees AJ
    Brain; 2010 Mar; 133(Pt 3):727-45. PubMed ID: 20305278
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Parkinson's disease and dopaminergic medication on proprioceptive processing.
    Mongeon D; Blanchet P; Messier J
    Neuroscience; 2009 Jan; 158(2):426-40. PubMed ID: 18996173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. On the role of dopamine replacement therapy in decision-making, working memory, and reward in Parkinson's disease: does the therapy-dose matter?
    Torta DM; Castelli L; Zibetti M; Lopiano L; Geminiani G
    Brain Cogn; 2009 Nov; 71(2):84-91. PubMed ID: 19442427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Parkinson's disease duration determines effect of dopaminergic therapy on ventral striatum function.
    MacDonald AA; Monchi O; Seergobin KN; Ganjavi H; Tamjeedi R; MacDonald PA
    Mov Disord; 2013 Feb; 28(2):153-60. PubMed ID: 23165957
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Iowa Gambling Task in Parkinson's disease: A meta-analysis on effects of disease and medication.
    Evens R; Hoefler M; Biber K; Lueken U
    Neuropsychologia; 2016 Oct; 91():163-172. PubMed ID: 27475264
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects of dopaminergic medication on basic motor performance and executive functions in Parkinson's disease.
    Michely J; Barbe MT; Hoffstaedter F; Timmermann L; Eickhoff SB; Fink GR; Grefkes C
    Neuropsychologia; 2012 Aug; 50(10):2506-14. PubMed ID: 22776611
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multisensory determinants of orientation perception in Parkinson's disease.
    Barnett-Cowan M; Dyde RT; Fox SH; Moro E; Hutchison WD; Harris LR
    Neuroscience; 2010 Jun; 167(4):1138-50. PubMed ID: 20206672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dopaminergic modulation of cognitive interference after pharmacological washout in Parkinson's disease.
    Fera F; Nicoletti G; Cerasa A; Romeo N; Gallo O; Gioia MC; Arabia G; Pugliese P; Zappia M; Quattrone A
    Brain Res Bull; 2007 Sep; 74(1-3):75-83. PubMed ID: 17683792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of influence of task difficulty on perceptual decision making by STN deep brain stimulation.
    Green N; Bogacz R; Huebl J; Beyer AK; Kühn AA; Heekeren HR
    Curr Biol; 2013 Sep; 23(17):1681-4. PubMed ID: 23932401
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 66.